BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allianz Asset Management GmbH | 33,300 | $235,764 | 0.00% |
| Allspring Global Investments Holdings, LLC | 2,478 | $17,544 | 0.00% |
| Bell Investment Advisors, Inc | 132 | $935 | 0.00% |
| TFO Wealth Partners, LLC | 3 | $21 | 0.00% |
| EverSource Wealth Advisors, LLC | 100 | $708 | 0.00% |
| Financial Gravity Asset Management, Inc. | 2 | $10 | 0.00% |
| Lindbrook Capital, LLC | 331 | $2,343 | 0.00% |
External links
This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.